DelveInsight Business Research Press Releases

• Published on February 12, 2025 - 21:00 GMT

  

  Oncolytic Virus Therapies Market Expected to Experience Major Growth by 2034, According to DelveInsight

  DelveInsight’s Oncolytic Virus Therapies Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Oncolytic Virus Therapies …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 20:59 GMT

  

  HER2-Positive Breast Cancer Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis

  LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- As per DelveInsight’s assessment, globally, HER2-Positive Breast Cancer pipeline constitutes 50+ key companies continuously working towards developing 55+ HER2-Positive Breast Cancer …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 20:58 GMT

  

  Advanced Ovarian Cancer Pipeline 2024: Mechanism of Action, Route of Administration, and Clinical Trial Insights

  LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- As per DelveInsight’s assessment, globally, Advanced Ovarian Cancer pipeline constitutes 50+ key companies continuously working towards developing 50+ Advanced Ovarian Cancer treatment …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 14:21 GMT

  Leptomeningeal Metastases Market Set to Expand at a CAGR of ~3% Through 2034 | DelveInsight

  Leading companies like AstraZeneca and Angiochem are spearheading advancements, redefining patient treatment possibilities. LAS VEGAS , NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Leptomeningeal Metastases Market Insights, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 14:21 GMT

  Plexiform Neurofibroma Market Set for Significant Expansion by 2034 | DelveInsight

  Leading companies like AstraZeneca and MSD are spearheading advancements, redefining patient treatment possibilities. LAS VEGAS , NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Plexiform Neurofibroma Market Insights, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 14:13 GMT

  Neuroendocrine Prostate Cancer Market on Track for Transformative Growth by 2032 | DelveInsight

  Leading companies like Amgen and BioXcel Therapeutics are spearheading advancements, redefining patient treatment possibilities. LAS VEGAS , NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Neuroendocrine Prostate Cancer …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 14:13 GMT

  Pancreatic Ductal Adenocarcinoma Market Set for Significant Expansion by 2032 | DelveInsight

  Leading companies like Cardiff Oncology, XOMA, and Alphamab are spearheading advancements, redefining patient treatment possibilities. LAS VEGAS , NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Pancreatic Ductal …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 14:00 GMT

  T-cell Receptor Therapy Market Poised for Remarkable Growth by 2032 | DelveInsight

  Leading companies like Corcept Therapeutics and Crinetics Pharmaceuticals are spearheading advancements and redefining patient treatment possibilities. LAS VEGAS , NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “T-cell …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 13:29 GMT

  

  Cytokine Release Syndrome Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND

  Cytokine Release Syndrome Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Cytokine Release Syndrome Pipeline Insight” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 12:58 GMT

  

  STAT Inhibitors Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

  STAT Inhibitors Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “STAT Inhibitors Pipeline Insight” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in STAT Inhibitors …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 12:35 GMT

  

  PARP Inhibitors Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

  PARP Inhibitors Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “PARP Inhibitors Pipeline Insight” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in PARP Inhibitors …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 12:28 GMT

  

  Hypertriglyceridemia Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND

  Hypertriglyceridemia Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Hypertriglyceridemia Pipeline Insight” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 12, 2025 - 12:16 GMT

  

  Peripheral T-cell Lymphoma Clinical Trials:- EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, Companies

  Peripheral T-cell Lymphoma Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Peripheral T-cell Lymphoma Pipeline Insight” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 18:34 GMT

  

  Erythromelalgia Pain Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight

  DelveInsight’s Erythromelalgia Pain Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Erythromelalgia Pain Market …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 18:34 GMT

  

  Craniopharyngioma Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight

  DelveInsight’s Craniopharyngioma Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Craniopharyngioma Market Insights, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 18:34 GMT

  

  Erdheim-Chester Disease Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight

  DelveInsight’s Erdheim-Chester Disease Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Erdheim-Chester Disease …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 18:34 GMT

  

  Blastic Plasmacytoid Dendritic Cell Neoplasm Market to Show Remarkable Growth Trends by 2032, DelveInsight Reports

  DelveInsight’s Blastic Plasmacytoid Dendritic Cell Neoplasm Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Blastic …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 18:34 GMT

  

  Adult T-Cell Leukemia-Lymphoma Market Revenue to Expand Significantly by 2034, States DelveInsight Report

  DelveInsight’s Adult T-Cell Leukemia-Lymphoma Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Adult T-Cell Leukemia- …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 15:27 GMT

  Hairy Cell Leukemia Market to Experience Remarkable Growth by 2034, Says DelveInsight

  Stay ahead in the Hairy Cell Leukemia market! DelveInsight’s latest 7MM report reveals essential epidemiology insights and market forecasts. LAS VEGAS , NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Hairy Cell Leukemia - …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 11, 2025 - 15:27 GMT

  Chronic Lymphocytic Leukemia Market Set for Transformative Growth by 2034, Reports DelveInsight

  How is the Chronic Lymphocytic Leukemia market transforming? DelveInsight’s latest 7MM report delves into critical epidemiology data and market trends. LAS VEGAS , NV, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Chronic …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...